Levodopa/Carbidopa (4:1) ( DrugBank: Carbidopa, Levodopa )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 201 | Angelman syndrome | 1 |
201. Angelman syndrome
Clinical trials : 25 / Drugs : 40 - (DrugBank : 11) / Drug target genes : 22 - Drug target pathways : 20
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00829439 (ClinicalTrials.gov) | January 2009 | 26/1/2009 | Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome | A Dose-escalation Tolerability Study of Levodopa/Carbidopa in Angelman Syndrome | Angelman Syndrome | Drug: Levodopa/Carbidopa (4:1) | Boston Children’s Hospital | NULL | Completed | 4 Years | 12 Years | All | 16 | Phase 1 | United States |